{
  "question_stem": {
    "en": "A 62-year-old woman is brought to the emergency department after a fall and is found to have a left femoral neck fracture. The patient is admitted to the hospital, and a hip arthroplasty is planned. Medical history is significant for long-standing type 2 diabetes mellitus, hypertension, hyperlipidemia, and migraines. While hospitalized, the patient receives a combination of long- and short-acting insulin for diabetes management. On the morning of surgery, fasting blood glucose level is 42 mg/dL. The patient is awake and alert and says she feels hungry but has no other symptoms of hypoglycemia.",
    "zh": "一名62岁女性因摔倒被送往急诊科，发现左侧股骨颈骨折。患者被收治入院，并计划进行髋关节置换术。病史包括长期2型糖尿病、高血压、高脂血症和偏头痛。住院期间，患者接受长效和短效胰岛素联合治疗以控制糖尿病。术前早晨，空腹血糖水平为42 mg/dL。患者清醒、神志清醒，并表示感到饥饿，但没有其他低血糖症状。"
  },
  "question": {
    "en": "Concurrent use of which of the following medications best explains this finding?",
    "zh": "以下哪种药物的联合使用最能解释这一发现？"
  },
  "options": {
    "A": {
      "en": "Atorvastatin",
      "zh": "阿托伐他汀"
    },
    "B": {
      "en": "Doxazosin",
      "zh": "多沙唑嗪"
    },
    "C": {
      "en": "Hydrochlorothiazide",
      "zh": "氢氯噻嗪"
    },
    "D": {
      "en": "Losartan",
      "zh": "氯沙坦"
    },
    "E": {
      "en": "Propranolol",
      "zh": "普萘洛尔"
    },
    "F": {
      "en": "Verapamil",
      "zh": "维拉帕米"
    }
  },
  "correct_answer": "E",
  "explanation": {
    "en": "Sympathetic system neurotransmitters raise blood glucose in response to hypoglycemia via sympathetic nervous system activation (ie, norepinephrine/epinephrine release) and increase secretion of glucagon, cortisol, and growth hormone.\n\nSymptoms of hypoglycemia fall into 2 general categories: neurogenic (autonomic) and neuroglycopenic.\n\n*   **Neurogenic symptoms** are mediated via norepinephrine/epinephrine and acetylcholine release during sympathetic stimulation. Symptoms due to norepinephrine/epinephrine include tremulousness, tachycardia, and anxiety/arousal, whereas **acetylcholine** causes sweating, hunger, and paresthesias.\n*   **Neuroglycopenic symptoms** are due to inadequate availability of glucose in the CNS and include behavioral changes, confusion, visual disturbances, stupor, and seizures.\n\nThis patient has reduced awareness of hypoglycemia, likely due to the use of a nonselective beta blocker (eg, propranolol) for chronic treatment of migraines and/or hypertension. Nonselective beta blockers attenuate the norepinephrine/epinephrine-mediated symptoms of hypoglycemia, but cholinergic symptoms (eg, hunger) are unaffected. In addition, nonselective beta blockers can contribute to the severity of hypoglycemia; epinephrine stimulates hepatic gluconeogenesis and peripheral glycogenolysis, but this effect is diminished by nonselective beta blockers.\n\n(Choices A and C) Statins (eg, atorvastatin) and hydrochlorothiazide can increase blood glucose levels but would not mask symptoms of hypoglycemia.\n\n(Choice B) Insulin-secreting pancreatic beta cells have alpha-2 and beta-2 receptors; stimulation of alpha-2 receptors inhibits insulin secretion, whereas stimulation of beta-2 receptors increases insulin secretion. Doxazosin is a selective alpha-1 blocker and has no effect on glucose levels.\n\n(Choices D and F) Angiotensin II receptor blockers (eg, losartan) and nondihydropyridine calcium channel blockers (eg, verapamil) do not mask the symptoms of hypoglycemia and have virtually no effect on glucose levels.\n\nEducational objective:\nNonselective beta blockers exacerbate hypoglycemia and mask hypoglycemic symptoms mediated by norepinephrine/epinephrine. {{exhibit_1}}",
    "zh": "交感神经系统神经递质通过交感神经系统激活（即去甲肾上腺素/肾上腺素释放）来升高血糖以应对低血糖，并增加胰高血糖素、皮质醇和生长激素的分泌。\n\n低血糖的症状分为两大类：神经源性（自主神经）和神经性低血糖。\n\n*   **神经源性症状** 通过交感神经刺激期间去甲肾上腺素/肾上腺素和乙酰胆碱的释放来介导。由去甲肾上腺素/肾上腺素引起的症状包括震颤、心动过速和焦虑/兴奋，而**乙酰胆碱** 引起出汗、饥饿和感觉异常。\n*   **神经性低血糖症状** 是由于中枢神经系统葡萄糖供应不足引起的，包括行为改变、意识模糊、视力障碍、昏迷和癫痫发作。\n\n该患者对低血糖的意识降低，可能由于长期使用非选择性β受体阻滞剂（例如，普萘洛尔）来治疗偏头痛和/或高血压。非选择性β受体阻滞剂会减弱去甲肾上腺素/肾上腺素介导的低血糖症状，但胆碱能症状（例如饥饿感）不受影响。此外，非选择性β受体阻滞剂可能会加重低血糖的严重程度；肾上腺素刺激肝糖异生和外周糖原分解，但这种作用被非选择性β受体阻滞剂减弱。\n\n（选项 A 和 C）他汀类药物（例如，阿托伐他汀）和氢氯噻嗪可以升高血糖水平，但不会掩盖低血糖的症状。\n\n（选项 B）胰岛素分泌性胰腺β细胞具有α-2和β-2受体；刺激α-2受体抑制胰岛素分泌，而刺激β-2受体增加胰岛素分泌。多沙唑嗪是一种选择性α-1受体阻滞剂，对血糖水平没有影响。\n\n（选项 D 和 F）血管紧张素II受体阻滞剂（例如，氯沙坦）和非二氢吡啶类钙通道阻滞剂（例如，维拉帕米）不会掩盖低血糖的症状，并且对血糖水平几乎没有影响。\n\n教育目标：\n非选择性β受体阻滞剂会加重低血糖并掩盖由去甲肾上腺素/肾上腺素介导的低血糖症状。{{exhibit_1}}"
  },
  "summary": {
    "en": "This question tests knowledge of how nonselective beta-blockers can mask the adrenergic symptoms of hypoglycemia while leaving cholinergic symptoms intact. It also assesses understanding of the counterregulatory hormonal response to hypoglycemia.\n\nThe key to solving this question is recognizing that the patient is on insulin and has a low blood glucose level but only reports hunger. This discrepancy suggests a masking of typical adrenergic symptoms, which is a known side effect of nonselective beta-blockers.",
    "zh": "本题测试对非选择性β受体阻滞剂如何掩盖低血糖的肾上腺素能症状，同时保留胆碱能症状的理解。它还评估对低血糖的代偿性激素反应的理解。\n\n解决此问题的关键在于认识到患者正在使用胰岛素并且血糖水平较低，但仅报告了饥饿。这种差异表明典型肾上腺素能症状的掩盖，这是非选择性β受体阻滞剂的已知副作用。"
  },
  "tags": "Hypoglycemia; Beta-blockers; Diabetes mellitus; Autonomic nervous system; Neurogenic symptoms",
  "category": "Endo",
  "question_id": "1492",
  "has_exhibits": true,
  "exhibit_count": 1,
  "exhibit_files": [
    "image1.jpg"
  ],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Endo 23\\1492",
  "extracted_at": "2025-11-05T14:00:08.580450",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T17:37:20.184243",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}